Skip to Content

U.S. Drug Prices 256 Percent Higher Than in 32 OECD Countries

THURSDAY, Jan. 28, 2021 -- In 2018, prices for drugs in the United States were 256 percent higher than those in 32 Organisation for Economic Co-operation and Development (OECD) comparison countries, according to a report published online Jan. 28 by the RAND Corporation.

Andrew W. Mulcahy, Ph.D., from the RAND Corporation in Santa Monica, California, and colleagues compared 2018 drug prices in the United States to those in 32 OECD countries. The prices for several subsets of drugs were calculated and compared.

The researchers found that when analyzing data for all prescription drugs available in the United States and comparison countries in 2018, U.S. prices for drugs were 256 percent higher than those in the comparison countries combined. For brand-name originator drugs, U.S. prices were even higher than those in comparison countries (344 percent higher) but were lower than those in comparison countries for unbranded generic drugs (U.S. prices were 84 percent of those in comparison countries). Unbranded generics represented 84 and 35 percent of volume in the United States and other countries, respectively. A consistent pattern of considerably higher overall drug prices was seen in the United States versus comparison countries, although the magnitude was altered with different methodological decisions and assumptions.

"Brand-name drugs are the primary driver of the higher prescription drug prices in the U.S.," Mulcahy said in a statement. "We found consistently high U.S. brand name prices regardless of our methodological decisions."

More Information

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

Markers of Puberty Differ in Girls With More Body Fat

FRIDAY, Feb. 26, 2021 -- Girls with higher total body fat (TBF) have differences in hormonal and clinical markers of puberty in late puberty, according to a study published online...

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 22 to 26, 2021. This roundup...

Digital Self-Monitoring Linked to Weight Loss for Adults

FRIDAY, Feb. 26, 2021 -- Digital self-monitoring is associated with weight loss in behavioral interventions for overweight or obesity, according to a review published online Feb....

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.